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MYH9 is an Essential Factor 
for Porcine Reproductive and 
Respiratory Syndrome Virus 
Infection
Jiming Gao1,†, Shuqi Xiao1, Yihong Xiao2, Xiangpeng Wang1,#, Chong Zhang1, Qin Zhao1, 
Yuchen Nan1, Baicheng Huang1, Hongliang Liu1, Ningning Liu2,‡, Junhua Lv2,*, Taofeng Du1, 
Yani Sun1, Yang Mu1, Gang Wang3, Shahid Faraz Syed1, Gaiping Zhang4, Julian A. Hiscox5, 
Ian Goodfellow6 & En-Min Zhou1
Porcine reproductive and respiratory syndrome (PRRS) caused by the PRRS virus (PRRSV) is an 
important swine disease worldwide. PRRSV has a limited tropism for certain cells, which may at least 
in part be attributed to the expression of the necessary cellular molecules serving as the virus receptors 
or factors on host cells for virus binding or entry. However, these molecules conferring PRRSV infection 
have not been fully characterized. Here we show the identification of non-muscle myosin heavy chain 
9 (MYH9) as an essential factor for PRRSV infection using the anti-idiotypic antibody specific to the 
PRRSV glycoprotein GP5. MYH9 physically interacts with the PRRSV GP5 protein via its C-terminal 
domain and confers susceptibility of cells to PRRSV infection. These findings indicate that MYH9 is an 
essential factor for PRRSV infection and provide new insights into PRRSV-host interactions and viral 
entry, potentially facilitating development of control strategies for this important swine disease.
Porcine reproductive and respiratory syndrome (PRRS) is a highly infectious porcine disease, and has become a 
global epidemic since its initial emergence in the US and Europe in the late 1980s, and early 1990s1–3, respectively. 
Due to causing severe reproductive failure and a high rate of late abortion and early farrowing in sows, and res-
piratory disease and mortality in young pigs4,5, PRRS is now widely recognized as one of the most economically 
significant diseases in the pork industry worldwide6.
The causative agent, PRRS virus (PRRSV), is a positive sense, single-stranded RNA virus, with a genome of 
approximately 15 kb in length. It is classified as a member of the Arteriviridae family, in the Nidovirales order7. 
Two major genotypes of PRRSV, European (type 1) and North American (type 2), have been identified based on 
their genetic and antigenic characteristics8. In addition, PRRSV appears to continue to evolve leading to the emer-
gence of additional subgenotypes9,10, as well as the highly pathogenic PRRSV (HP-PRRSV) strains in China11–13.
The PRRSV genome encodes ten open reading frames (ORFs). The first two ORFs (ORF1a and ORF1b) encode 
replicase proteins whereas ORF2a, ORF2b, ORF3, and ORF4 encode four membrane-associated glycoproteins, 
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designated as GP2a, E, GP3, and GP4, respectively. ORFs 5–7 encode three major structural proteins of the virion: 
the envelope glycoprotein GP5, the non-glycosylated membrane protein M, and the nucleocapsid protein N14,15. 
Recently, a novel structural protein GP5a was identified and encoded by newly identified ORF5a16.
PRRSV has a specific tropism for cells derived from the monocytic lineage, particularly differentiated mac-
rophages such as porcine alveolar macrophages (PAMs)17. MARC-145 cells, derived from the African green mon-
key kidney cell line MA-104, are highly susceptible to PRRSV infection in vitro18,19. The limited tropism of PRRSV 
may at least in part be explained by the expression of certain cell-type specific receptors on host cells. Up to now, 
at least 6 molecules have been identified as PRRSV candidate receptors20. Among these molecules, CD163 has 
been shown to be indispensable for the infection21–25 and SIGLEC1 or CD169 has recently been confirmed as 
unrequired for PRRSV infection26. The scavenger receptor CD163 has been found to be a key factor for PRRSV 
infection. Expression of external CD163 protein in cells typically not susceptible to PRRSV confers the cell per-
missive22,25. Furthermore, the role of CD163 is proposed to be responsible for virus particles trafficking into early 
endosomes to facilitate a productive infection23, and PRRSV GP2a/4 glycoprotein complexes was identified to 
be interacting with CD163 for virus entry into susceptible host cell24. A recent study indicated that CD163 gene 
deleted pigs are fully protected from PRRSV infection21.
Previously, by using the anti-idiotypic monoclonal antibody (Mab2-5G2) to the idiotypic antibodies against 
the PRRSV GP5 protein, we identified a cellular protein with a molecular mass of 230 kDa in both MA-104 and 
PAMs interacting with Mab2-5G227. In this study, we further demonstrated that this protein was identified as 
non-muscle myosin heavy chain 9 (MYH9) and that MYH9 was involved in PRRSV infection acting as an essen-
tial factor by the physical interaction with the GP5 protein of PRRSV via its C-terminal domain. MYH9 provided 
a bridge between the attachment of virus particles to cell surface receptors and the subsequent un-coating events 
required for genomic release within the host cell.
Results
Interaction of MYH9 with PRRSV GP5. Our previous study showed that the anti-idiotypic monoclo-
nal antibody (Mab2-5G2) recognized a cellular protein in MA-104 cells and PAMs with the molecular mass of 
approximately 230 kDa27. Further analysis suggested that this protein was MYH9 (Supplementary Fig. 1a,b).
To confirm the interaction between GP5 and MYH9, MARC-145, PK-15, and COS-7 cell lines stably express-
ing FLAG-tagged GP5 (GP5Flag) were generated, as controls, MARC-145, PK-15, and COS-7 cell lines stably 
expressing the FLAG-tagged PRRSV nucleocapsid (N) protein (NFlag) were also constructed (Supplementary 
materials and methods; Supplementary Fig. 2). The location of GP5 and MYH9 in the cells was examined by 
confocal microscopy. In MARC-145 cells stably expressed GP5Flag, but not NFlag, was located together with MYH9 
(Fig. 1a). The interaction between GP5 and MYH9 was confirmed by co-immunoprecipitation using anti-MYH9 
or anti-FLAG antibodies. As shown in Fig. 1b, MYH9 co-precipitated with GP5Flag in MARC-145-GP5Flag cells, 
but not with NFlag in MARC-145-NFlag cells. In turn, GP5Flag co-precipitated with MYH9 in MARC-145-GP5Flag 
cell lysates, while NFlag did not co-precipitate with MYH9 in MARC-145-NFlag cell lysates. Taken together, these 
results indicate that GP5 was physically interacted with MYH9.
MYH9 interacts with PRRSV at the early stage of virus infection. PRRSV was incubated with 
MARC-145 cells and PAMs at MOI of 100 at 4 °C for 1 hr to allow the virus binding, followed by a shift to 37 °C 
to facilitate virus entry. At 0, 5, 15, 30 min and 1, 2, 4, 6, 8, 12 hrs after shifting to 37 °C, the cells were then fixed 
and the location of MYH9 and PRRSV were detected with the corresponding antibodies. PRRSV and MYH9 
were located together in MARC-145 cells (Fig. 2a) and PAMs (Fig. 2b) between 15 min to 2 hrs after the cells were 
shifted to 37 °C, but not after 4 hrs post infection (Supplementary Fig. 3a,b). In addition, PRRSV infection lead to 
a significant increase in MYH9 mRNA and protein levels in MARC-145 cells and PAMs (Fig. 2c,d). These results 
confirmed that the interaction of PRRSV with MYH9 occurred at the early stage of virus infection and that the 
expression of MYH9 was stimulated by PRRSV infection.
MYH9 is normally localized in the cytoplasm of cells28, however, during the entry of Herpes Simplex Virus-1 
(HSV-1) into cells, MYH9 is redistributed to the cell surface29. To investigate whether this redistribution also 
occurs during PRRSV infection, MARC-145 cells were inoculated with PRRSV (MOI 100) at 4 °C for 1hr to 
allow the virus binding, followed by a shift to 37 °C to facilitate virus entry. At 0, 5, 15, and 30 min after shifting to 
37 °C, the cells were fixed with 4% paraformaldehyde and cell membrane-associated MYH9 were detected using 
anti-MYH9 antibody. As shown in Fig. 2e, at 0 and 5 min after temperature change, no MYH9 was detected on the 
plasma membrane of MARC-145 cells. However, a remarkable enrichment of MYH9 was observed on the plasma 
membrane at 15 and 30 min after the shift to 37 °C. However, when PRRSV premixed with pig anti-PRRSV serum 
to block the PRRSV attachment, MYH9 was not detected on the plasma membrane. These results suggest that 
PRRSV infection induced MYH9 redistribution from the cytoplasm to the cell surface similarly to that observed 
in HSV-1 infection and that MYH9 interacted with PRRSV during the early stage of virus infection.
MYH9 is involved in PRRSV infection. To evaluate whether MYH9 contributes to productive PRRSV 
infection, a MARC-145 cell line was engineered to stably express an artificial microRNA (amiRNA) against 
MYH9 (MARC-145amiRMYH9) (Supplementary Fig. 4a). The levels of MYH9 mRNA and protein in the MARC-
145amiRMYH9 cells were significantly decreased compared to the control cells (Supplementary Fig. 4b,c) without 
any alteration of cell viability or growth kinetics compared to their parental cells (Supplementary Fig. 4d). The 
suppression of MYH9 expression significantly reduced PRRSV infection in MARC-145amiRMYH9 cells (Fig. 3a, left 
panel), but had no effect on rotavirus replication (Fig. 3a, right panel).
To further examine the role of MYH9 in PRRSV replication, a MARC-145 cell line was engineered to overex-
press MYH9 (MARC-145MYH9) (Supplementary Fig. 4e,f). Overexpression of MYH9 markedly increased the yield 
of PRRSV (Fig. 3b, left panel), but did not affect the yield of porcine rotavirus (Fig. 3b, right panel).
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Figure 1. Interaction of GP5 with MYH9. (a) The cellular localization of the FLAG-tagged protein (green) or 
MYH9 (red) was imaged by confocal microscopy after staining with specific antibodies. DAPI counterstaining 
of nuclei (blue) is shown in merged images. Scale bars, 10 μ m. (b) Co-immunoprecipitation of FLAG-tagged 
protein and MYH9 in MARC-145-NFlag and MARC-145-GP5Flag cell lysates using rabbit anti-MYH9 or rabbit 
anti-FLAG M2 antibodies. Co-IP products were analyzed by immunoblotting with mouse anti-FLAG M2 or 
Mab2-5G2 antibodies.
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Previous report demonstrated that MYH10 was detected in the MARC-145 cells30. To examine the associa-
tion of PRRSV infection with MYH10 upon viral infection, small interference RNA (siRNA) targeting MYH10 
(Supplementary Table 1) was applied to down-regulate MYH10 expression in MARC-145 cells. PRRSV infection 
assay result indicated that down-regulation of MYH10 did not affect virus production (Fig. 3c). To evaluate the 
effect of MYH9 or MYH10 expression on CD163 gene expression level in MARC-145, the mRNA fold changes of 
CD163 in MARC-145, MARC-145amiRNC, MARC-145amiRMYH9, MARC-145puro, MARC-145MYH9, MARC-145siNC 
and MARC-145siMYH10 were tested by relative quantitative RT-PCR. The result showed that CD163 gene level 
Figure 2. PRRSV co-located with MYH9 in the cells at early stage of PRRSV infection. MARC-145 cells  
(a) and PAM cells (b) were infected with PRRSV at an MOI of 100 at 4 °C for 1 hr, followed by a temperature 
shift to 37 °C for 0, 5, 15, 30 mins and 1, 2, 4, 6, 8, 12 hrs and then fixed, stained with rabbit anti-MYH9 and pig 
anti-PRRSV antibodies, and analyzed by confocal microscopy. The location of MYH9 (red) and PRRSV (green) 
in MARC-145 cells and PAMs at 4, 6, 8 and 12 hrs was shown in Supplementary Fig. 4a,b. Scale bars, 10 μ m.  
(c) MYH9 mRNA relative level in PRRSV infected and mock infected MARC-145 cells and PAMs was tested by 
quantitative RT-PCR. The data was normalized to MYH9 mRNA level in mock infected cells at 37 °C for 0 hrs. 
Error bars, mean ± s.e.m. (n = 3). (d) MYH9 protein level in PRRSV infected and mock infected MARC-145 
cells and PAMs was tested by Western blot using the indicated antibodies. The samples from left to right were 
PRRSV mock infected and infected cells lysates. The α -tubulin was tested as a loading control. (e) After PRRSV 
binding to MARC-145 cells at 4 °C for 1 hr, the cells were shifted to 37 °C for 0, 5, 15, and 30 min and fixed 
without permeabilization. MYH9 (red) localization was visualized by confocal microscopy after staining with 
specific antibodies. PRRSV pre-mixed with pig anti-PRRSV serum before infecting MARC-145 cells, and mock 
infected MARC-145 cells were used as the parallel controls. Nuclei (blue) were stained with DAPI. Scale bars, 
10 μ m.
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Figure 3. MYH9 expression level correlates with PRRSV infection. (a) TCID50 of PRRSV progeny virus titers 
in supernatant samples from cells with down-regulated MYH9 and western blot detection of MYH9 and PRRSV 
nuclear protein in the infected cells. The α -tubulin was tested as a loading control (left panel); TCID50 of pig 
rotavirus and western blot detection of MYH9 and pig rotavirus VP6 protein (right panel). (b) The effects of 
MYH9 overexpression on PRRSV (left panel) or pig rotavirus (right panel) replication in MARC-145 cells.  
(c) TCID50 of PRRSV progeny virus titers in supernatant samples from cells treated with MYH10 siRNA 
(siMYH9) or negative control siRNA (siNC) and Western blot detection of MYH9, MYH10 and PRRSV nuclear 
protein in the infected cells. (d) CD163 mRNA fold changes in MYH9 knockdown or overexpression cell lines, 
and in MYH10 knockdown cells. Error bars, mean ± s.e.m. (n = 3) *P < 0.05, **P < 0.01.
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did not change once the MYH9 or MYH10 expression was modulated (Fig. 3d). In addition, MYH9 C-terminal 
region protein (designated PRAHis), but not MYH10 C-terminal region protein (designated PRBHis), interacted 
with Mab2-5G2 (Supplementary material and method; Supplementary Fig. 1c). Taken together, these results 
demonstrated that MYH9, not MYH10, is involved in PRRSV infection.
MYH9 is an essential factor in the association with CD163 facilitating susceptibility to 
PRRSV. Expression of CD163, a key receptor in PRRSV susceptibility, confers the unsusceptible cell lines to 
be PRRSV permissive25. PK-15 cells lack CD163 but express MYH9 (Supplementary Fig. 5a,b), while COS-7 cells 
lack both31 (Supplementary Fig. 5a,c). To further examine the potential role of MYH9 in PRRSV infection, PK-15 
and COS-7 cells were engineered to express CD163 alone or both CD163 and MYH9 to generate PK-15CD163, 
COS-7CD163, and COS-7CD163+MYH9 cell lines (Supplementary Fig. 5d). Following PRRSV infection, PRRSV N pro-
tein could be detected in MARC-145, PK-15CD163, and COS-7CD163+MYH9 cells, but not in PK-15puro, COS-7puro, or 
COS-7CD163 control cells (Fig. 4a). At 72 hrs post infection, infectious PRRSV particles were also detected from the 
supernatant samples from MARC-145, PK-15CD163, or COS-7CD163+MYH9 cells, but not in PK-15puro, COS-7puro, or 
COS-7CD163 cell supernatant samples (Fig. 4b). The interaction of MYH9 with CD163 was examined using BiFC 
system (Supplementary materials and methods). The preliminary results showed that MYH9 C-terminal region 
(described below) interacted with CD163 tail domain (Supplementary Fig. 6).
Generally, newly produced infectious progeny virus is not detected until 8–12 hrs after PRRSV binding to 
host cells32. Therefore, the intracellular levels of the RNA encoding PRRSV N by qRT-PCR during the early phase 
of viral infection can be used to quantify viral binding to cells, virus uncoating and virus replication at the early 
stage of infection. The results showed that there were no differences in RNA levels of PRRSV N gene after PRRSV 
binding to cells at 4 °C. However, following shifting to 37 °C for 2 hrs, the level of PRRSV N RNA associated with 
the cells decreased than that at 0 hr, suggesting that not all bound virus can enter the target cells. The result also 
demonstrated that N gene level in COS-7 and COS-7CD163 cells was much lower than that in COS-7CD163+MYH9 and 
MARC-145 cells at 2 and 4 hrs after shifting to 37 °C, and at 6 and 8 hrs, the N gene level in COS-7CD163+MYH9 and 
MARC-145 cells was significantly increased (Fig. 4c). These findings indicated that MYH9 was not responsible 
for PRRSV binding to the cells, but the efficient PRRSV entry into COS-7 cells was depended on the expression of 
both CD163 and MYH9. Together, these results demonstrated that MYH9 present is essential for efficient PRRSV 
infection of the cells.
The C-terminal region of MYH9 is involved in PRRSV infection. To investigate whether GP5 inter-
acts with the C-terminal domain of MYH9, purified PRAHis protein (supplementary Fig. 7a,b) was used to probe 
the cells expressing GP5Flag or NFlag. As shown in Fig. 5a, PRAHis bound to PK-15-GP5Flag or COS-7-GP5Flag, but 
not PK-15-NFlag or COS-7-NFlag control cells, indicating that a GP5 binding site was located in the C-terminal 
domain (aa1651–1960) of MYH9.
To evaluate the effects of PRAHis on PRRSV infection, rabbit anti-PRAHis serum was generated (Supplementary 
Fig. 7c). The recombinant PRRSV-EGFP strain33 was pre-mixed with anti-PRAHis serum and then incubated with 
MARC-145 cells for 1 hr at 4 °C to allow the virus binding. Quantitative RT-PCR demonstrated that incubation 
with anti-PRAHis serum did not block initial virus binding (Fig. 5b). However, when the cells were shifted to 
37 °C and incubated for 30 min before washing out the virus/antisera mixture, the anti-PRAHis serum did inhibit 
PRRSV infection of MARC-145 cells in a dose-dependent manner (Fig. 5c). In contrast, when the mixture was 
washed out before the cell culture was shifted to 37 °C, the anti-PRAHis serum had no effect on viral infection 
(Fig. 5d). These results indicated that antiserum to MYH9 blocked PRRSV infection at a post binding step, most 
likely during the entry and/or the uncoating phase of the viral life cycle.
Blebbistatin inhibits PRRSV infection in vitro and in vivo. Blebbistatin, a specific inhibitor of myosin 
II ATPase activity34, was used to further invesigtate the role of MYH9 during PRRSV infection. Blebbistatin was 
found to inhibit PRRSV infection of MARC-145 cells and PAMs in a dose-dependent manner (Fig. 6a,b). The 
potential role of MYH9 on PRRSV infection was also investigated in vivo using a piglet model of infection. Piglets 
were either mock treated with PBS or treated with blebbistatin via intranasal delivery prior to PRRSV infec-
tion. Virus titers and piglet survival rates were then examined over a period of 21 days. Blebbistatin significantly 
reduced the viral load in serum at 7 days post infection (Fig. 6c). Moreover, blebbistatin treatment resulted in 
survival of 4/5 piglets, whereas 100% mortality was observed in piglets that did not receive blebbistatin (Fig. 6d). 
Piglets challenged with PRRSV demonstrated severe interstitial pneumonic lesions, decreased thymic lobule size, 
blurred boundaries between the thymic cortex and medulla, as well as decreased number of thymocytes in the 
medulla. In contrast, histological analyses indicated that the alveolar septa of lung were widened and mild patho-
logical change was found in thymus with few thymocytes deleting in the medulla in PRRSV pigs that received 
blebbistatin (Fig. 6e). Taken together, these results indicated that MYH9 played an essential role in PRRSV infec-
tion both in vitro and in vivo.
Discussion
Our previous work has shown that the anti-idiotypic monoclonal antibody, Mab2-5G2, generated against 
anti-PRRSV GP5 antibody recognized a 230 kDa protein from PRRSV permissive MA-104 cells and PAMs27. 
Anti-idiotypic antibody may bear a structural similarity to the GP5 itself35, therefore, the GP5 and Mab2-5G2 share 
common ability to interact with the cellular receptor of PRRSV36–38. Protein sequencing identified MYH9 as the 
potential binding partner of the anti-idiotypic antibody Mab2-5G2, suggesting that PRRSV GP5 may interact with 
MYH9. In this study, our results confirmed that PRRSV GP5 interacted with MYH9 in PRRSV permissive MARC-
145 cells. Specifically, PRRSV GP5 was shown to interact with the C-terminal region of MYH9 (AA1651–1960) 
and this interaction occurred at the early stage of PRRSV infection.
www.nature.com/scientificreports/
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MYH9 expression level apparently increased after PRRSV incubating with host cells, indicating that PRRSV 
infection was relevant with MYH9 expression level. Interference of MYH9 expression in PRRSV permissive cells 
affected virus progeny production but not pig rotavirus, suggesting the MYH9 expression level is an essential 
factor for productive PRRSV replication. HSV-129 and severe fever with thrombocytopenia syndrome virus 
(SFTSV)39 have been shown to trigger rapid redistribution of MYH9 to the cell surface. The present study demon-
strated the same pattern during PRRSV infection, possibly explaining why PRRSV infection can be inhibited by 
anti-PRAHis serum after the virus binding stage. This inhibition requires MYH9 redistribution to the cell surface, 
triggered by the entry of the virus, confirming that MYH9 interacts with GP5 after the virus binding stage.
Non-muscle myosin II 3 isoforms (MYH9, MYH10, and MYH14) exhibit a high level of amino acid sequence 
similarity except for their non-helical tail region40. Therefore, it has been proposed that different isoforms process 
Figure 4. MYH9 is essential for PRRSV infection. (a) MARC-145, PK-15, PK-15CD163, COS-7, COS-7CD163, 
and COS-7CD163+MYH9 cell lines infected with PRRSV were fixed at 72 hrs post infection and imaged by confocal 
microscopy after staining with mouse antibodies against PRRSV N proteins (red). Nuclei (blue) were counter 
stained with DAPI. Scale bars, 50 μ m. (b) TCID50 of progeny virus in the supernatant of the infected cells 72 hrs 
post infection. Error bars, mean ± s.e.m. (n = 3). *P < 0.05, **P < 0.01. (c) After allowing PRRSV bound to 
COS-7, COS-7CD163, COS-7CD163+MYH9, and MARC-145 cells at 4 °C for 1 hr, the cells were shifted to 37 °C for 0, 
2, 4, 6 or 8 hrs. From the total mRNA, relative mRNA levels of PRRSV N gene were measured across the time 
course using quantitative RT-PCR. Relative folds of the N gene levels are shown in comparison with the N level 
in the COS-7CD163 cells at 37 °C for 2 hrs. Error bars, mean ± s.e.m. (n = 3).
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redundant functions. As a HSV-1 entry receptor, MYH10 plays the same function as MYH9 for mediating HSV-1 
entry by interacting with gB41. However, our results showed that MYH10 playing minimum role in PRRSV infec-
tion. It suggested that GP5 specifically interacts with MYH9.
Enveloped viruses enter cells through a series of steps, beginning with interactions between viral surface 
proteins and cell surface molecules. This is followed by the activation of cellular pathways that lead to membrane 
fusion between virus envelope and cell membrane, or internalization of the virus particles, as well as releasing of 
the virus genome to cytoplasm. Most viruses utilize multiple attachment factors, receptors, or entry mediators 
simultaneously to entry cell42,43. Previously, CD163 was identified as a major receptor in PRRSV infection. When 
CD163 was expressed in PRRSV non-permissive cells such as PK-15 and BHK-21 cell lines, these cells became 
susceptible to PRRSV infection25,44. Importantly, all of these cells express MYH9. On the other hand, COS-7 cells, 
expressing MYH10 but not MYH9, did not support PRRSV infection even with CD163 expression. This further 
confirmed that MYH10 was not relevant with PRRSV infection. Only when CD163 and MYH9 were co-expressed 
in COS-7 cells did they become permissive for PRRSV.
Figure 5. C-terminus of MYH9 is the binding domain of PRRSV GP5. (a) PK-15-NFlag, PK-15-GP5Flag, 
COS-7-NFlag, and COS-7-GP5Flag cells were incubated with purified PRAHis at 4 °C for 1 hr, fixed after shifting to 
37 °C for 30 min and imaged by confocal microscopy after stained with antibodies specific for His (green) and 
FLAG (red). Nuclei (blue) were counterstained with DAPI. Scale bars, 5 μ m. (b) Anti-PRAHis serum dilutions 
were mixed with PRRSV-EGFP. The mixtures were incubated with MARC-145 cells at 4 °C for 1 hr, then cells 
were harvested and relative PRRSV binding levels were analyzed by quantitative RT-PCR. (c) After incubating 
with the mixtures at 4 °C for 1 hr, the cells were shifted to 37 °C for 30 min, and then washed to remove 
unbound virus. The quantity of PRRSV positive infected cells was analyzed by FACS 48 hrs post infection. Pre-
immunization serum (pre) at 1:10 served as the control. (d) After cells were incubated for 1 hr at 4 °C in the 
mixtures, the cells were washed with DMEM prior to a shift to 37 °C for 48 hrs. The number of PRRSV positive 
infected cells was analyzed by FACS. Pre-immunization serum (pre) at 1:10 served as the control. In both  
(c) and (d) the data were shown as relative percentages compared to the value of the pre-immunization serum 
sample, whose mean value was set as 100% infection. Error bars, mean ± s.e.m. (n = 3). *P < 0.05.
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Figure 6. Blebbistatin inhibits PRRSV infection in vitro and in vivo. (a) MARC-145 cells were infected with 
PRRSV-EGFP in the presence of the indicated concentrations of blebbistatin. The cells were analyzed by FACS 
48 hrs after infection. The data were shown as relative percentages compared to the value in the absence of 
blebbistatin, which the mean value was set at 100% infection. Error bars, mean ± s.e.m. (n = 3) (b) PAMs were 
infected with PRRSV in the presence of the indicated concentrations of blebbistatin. TCID50 of progeny virus 
titer was tested 24 hrs post infection. Error bars, mean ± s.e.m. (n = 3) (c) Virus titers in the serum samples of 
PRRSV infected pigs in PBS (mock) or blebbistatin treated groups 7 days after inoculation were determined by 
calculation of TCID50 on MARC-145 cells. Error bars, mean ± s.e.m. (n = 5 pigs per group) (d) Piglets received 
PBS (mock) or blebbistatin, and infected with PRRSV were monitored daily for mortality for 21 days.  
(e) Representative histopathological examinations for lung and thymus lesions stained by hematoxylin and 
eosin (H&E). Triangle indicates thickening of the alveolar septa or hyperaemia within alveolar septa. Arrow 
indicates inflammatory cells infiltrate. Scale bars, 200 μ m. *P < 0.05, **P < 0.01, *** P < 0.001.
www.nature.com/scientificreports/
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The binding of PRRSV was not different among the COS-7, COS-7CD163, and COS-7CD163+MYH9 cells, indicating 
that virus-cellular attachment is not dependent on CD163 or MYH9. The internalized virus assay result showed 
that some bound virus could enter COS-7CD163+MYH9 and MARC-145 cells after the cells were shifted to 37 °C for 
2 hrs. It is known that CD163 is not responsible for PRRSV binding to cells45, but productive PRRSV infection 
requires trafficking through CD163-positive early endosomes23. PRRSV may need MYH9 to participate in the 
stage following entry. These results may also explain why PRRSV has a very restricted cell tropism as MYH9 is 
ubiquitously expressed in various mammalian tissues and cells types. In this study, the titer of progeny virus in 
COS-7CD163+MYH9 cells was much lower than that in MARC-145 or PK-15 cells, suggesting that virus replication 
levels may relate to the expression level of MYH9. On the basis of these results, we propose that PRRSV binding 
and entry into permissive cells takes place in three stages. Stage I: PRRSV binds to the cell surface with the help 
of other cellular proteins, such as heparin sulphate46 and sialoadhesin47. Stage II: After binding to the cell surface, 
the PRRSV GP2a/GP4 complex interacts with CD16324, and MYH9 redistributes to the cell surface to bind GP5 
via a currently unknown mechanism. Stage III: MYH9 interacts with CD16348 and together support virus entry 
(Supplementary Fig. 6).
The blebbistatin inhibited PRRSV infection both in vitro and in vivo by preventing the contraction of MYH9 
and may decrease the internalization of the virus into endosomes and may in turn prevent CD163 from moving 
to the cell surface to interact with the virus. This suggests that targeting the function of cellular factors critical for 
virus replication could be a successful therapeutic strategy. Currently, HSV-129, Epstein-Barr virus49 and PRRSV 
(as reported in this study) have been known to utilize MYH9 as a functional receptor by interacting with virus 
specific protein. MYH9 has also been reported as a critical factor contributing to the efficiency of early infection 
of SFTSV in vitro50, and the activation of a Rho/NM II-dependent pathway facilitates Salmonella invasion51 or 
Sendai virus fusion with host cells52. The role of non-myosin II in infection of other pathogens remains an impor-
tant area for further research.
Materials and Methods
Cells and Viruses. PK-15, MARC-145, 293T, and COS-7 cells were purchased from China Center for Type 
Culture Collection (CCTCC, Wuhan, China). MARC-145 and 293T cells were grown in Dulbecco’s minimal 
essential medium (DMEM) supplemented with 10% fetal bovine serum FBS (Gibco, Carlsbad, CA, USA). PK-15 
and COS-7 cells were grown in minimal essential medium (MEM) supplemented with 10% FBS. PAMs were 
collected from PRRSV negative pigs (28 days old) and maintained in RPMI-1640 medium supplemented with 
10% FBS. Wild-type highly pathogenic PRRSV (HP-PRRSV) SD16 strain was isolated by plaque purification 
and grown in MARC-145 cells as previously described53. HP-PRRSV SD16-EGFP recombinant virus was engi-
neered as described previously33. Pig rotavirus (AV-55) was purchased from China Center of Veterinary Culture 
Collection and was propagated on MA-104 cells54.
Reagents. Monoclonal mouse antibodies against PRRSV-N and CD163, and Mab2-5G2, polyclonal mouse 
antibodies against GP5, polyclonal rabbit antibodies against PRAHis, and pig anti-PRRSV sera were produced and 
purified in house. Mouse antibodies against FLAG M2 (F3165), His (SAB4600386), and α -tubulin (T6074), rabbit 
antibodies against FLAG (F7425), MYH9 (M8064) and MYH10 (M7939) were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). Mouse antibodies against Rotavirus [A2] (ab181695) was purchased from Abcam 
(Cambridge, MA, USA). Rabbit antibodies against GFP (AG279) were purchased from Beyotime (Jiangsu, China). 
Alexa Fluor 488 (115545003) or Cy3 (115165164) conjugated goat anti-mouse IgG antibodies, FITC (111095045) 
or Cy3 (111165003) conjugated goat anti-rabbit IgG antibodies, Cy3 (713165003) conjugated goat anti-swine 
IgG antibodies, and HRP conjugated goat anti-mouse IgG antibodies (115035003) were purchased from Jackson 
Immunoresearch (West Grove, PA, USA). 4,6-diamidino-2-phenylindole (DAPI) (P36931) was purchased from 
Life Technologies (Grand Island, NY, USA). X-tremeGENE HP DNA Transfection Reagent (06366236001), 
X-tremeGENE siRNA Transfection Reagent (04476093001), FastStart Universal SYBR Green Master (Rox) 
(04913850001), gel extraction, PCR purification, plasmid isolation, total RNA purification kit, and molecular 
biology reagents including restriction enzymes, and reverse transcription reagents were purchased from Roche 
(Basel, Switzerland). T4 DNA ligase, Taq DNA polymerase and In-Fusion HD Cloning Kit (639648) were pur-
chased from Takara (Dalian, China). Isopropyl b-d-1-thiogalactopyranoside (IPTG) (R0392) was purchased from 
Thermo Scientific (St. Rockford, II, USA). Dynabeads Protein G (10003D) was purchased from Invitrogen (Grand 
Island, NY, USA). Blebbistatin (1760) was purchased from TOCRIS Bioscience (Houston, TX, USA).
Immunoprecipitation Assays. First, Dynabeads Protein G was coupled to either rabbit anti-MYH9 or 
rabbit anti-FLAG M2 antibody according to the manufacturer’s protocol. The cells of interest were harvested, 
washed with PBS, and lysed in TNE buffer29 containing a proteinase inhibitor cocktail (Sigma). After centrifuga-
tion, the supernatant was collected and then incubated with the coupled beads for 2 hrs at 4 °C. Antigen bound 
beads were washed 3 times with TNE buffer. The bound proteins were then eluted with glycine buffer (pH = 3.0) 
and analyzed by immunoblotting.
Virus Infection. To analyze the susceptibility of PRRSV to the different cell lines, the cells were inoculated 
with PRRSV at an MOI of 0.01 for 1 hr at 4 °C. After washing out unbound virus, the binding and replication levels 
of virus in different cell lines were quantified by real-time PCR for PRRSV N gene. At various time post infection, 
virus yields in the supernatant were measured by TCID50 assay in MARC-145 cells. For detecting the location of 
MYH9 or PRRSV at various time post infection, PRRSV at MOI of 100 (TCID50 = 106/ml with 1.4 ml) was used 
to incubate with MARC-145 cells for 1 hr at 4 °C for synchronizing PRRSV binding to the cells. For detecting the 
inhibition of PRRSV infection in the cells, the percentage of GFP positive cells from PRRSV-EGFP infected cells 
were analyzed by FACS at 48 hrs post infection and normalized by control. Trypsin-activated rotavirus (30 min at 
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37 °C with 10 mg/ml trypsin) propagated from MA-104 cells was added to MARC-145 cells at an MOI of 0.01 and 
adsorbed at 4 °C for 1hr, then shifted to 37 °C to allow virus replication54.
Inhibition of Virus Infection Assays. Rabbit anti-PRAHis sera and pre-immune sera were serially diluted 
and incubated with PRRSV-EGFP (MOI of 0.01). The mixture was added to MARC-145 cells in 24-well plates and 
incubated at 4 °C for 1 hr to allow virus binding to cells. After washing out the unbound virus, the virus bound 
to cells was analyzed by qRT-PCR. To analyze the effect of anti-PRAHis serum on PRRSV infection, two different 
experiments were set up. First, the virus-serum mixture was incubated with the cells at 4 °C for 1 hr to allow bind-
ing. The virus-serum mixture was not washed out until the cells were shifted to 37 °C and incubated for 30 min. 
The cells were then re-fed with the appropriate medium and 48 hrs after infection and analyzed by flow cytometry. 
Second, the virus-serum mixture was washed out before the cells were shifted to 37 °C.
For inhibition with blebbistatin, MARC-145 cells or PAMs were pre-treated with various concentrations of 
blebbistatin for 30 min and then inoculated with PRRSV-EGFP or PRRSV SD16 stain, respectively, at MOI of 
0.01. After removal of the inoculum, the cells were re-fed with medium containing the same concentrations of 
blebbistatin. For MARC-145 cells, cells were analyzed by flow cytometry 48 hrs after the infection and for PAMs, 
TCID50 of progeny virus titer was measured 24 hrs after the infection.
RNAi and Quantitative RT-PCR. Artificial microRNA expression vectors were transfected into the 
cells for down regulating MYH9 expression according to the protocol of X-tremeGENE HP DNA Transfection 
Reagent and the stably transfected cells were selected. siRNAs targeting MYH10 gene and negative control 
siRNA (Supplementary table 1 26–29) were transiently transfected into the cells according to the instruction 
of X-tremeGENE siRNA Transfection Reagent. Total RNA was extracted using High Pure RNA Isolation Kit 
(Roche). Relative mRNA levels of PRRSV N gene, MYH9 and CD163 were determined using primers 14–19 listed 
in Supplementary Table 1, and normalized to β -Actin mRNA levels, amplified using primers 20 and 21 listed in 
Supplementary Table 1. The quantification was performed in Step One Plus Real-Time PCR System (Applied 
Biosystems) using FastStart Universal SYBR Green Master.
Indirect Immunofluorescence Assay. Cells were grown on top of microscope coverslips in 24-well tissue 
culture plates (801007; NEST). At each experimental endpoint, the cells were fixed with 4% paraformaldehyde for 
10 min at room temperature (RT), and permeabilized with 0.2% Triton X-100 in PBS at RT for 10 min. The cells 
were subsequently blocked with 1% bovine serum albumin (BSA) in PBS for 30 min at RT and then incubated 
with the indicated primary antibodies for 2 hrs. After washing five times with PBS, the cells were incubated for 
1 hr at RT with Fluor-labeled goat polyclonal antibodies: Alexa Fluor 488 or Cy3 conjugated goat anti-mouse 
IgG antibodies, FITC or Cy3 conjugated goat anti-rabbit IgG antibodies, Cy3 conjugated goat anti-swine IgG 
antibodies. Finally, the cells were counterstained with DAPI, and cell staining was visualized using A1R Resonant 
Scanning Confocal Microscope (Nikon) running NIS-Elements imaging software.
Immunoblotting. Proteins were separated on a NuPAGE 4–20% gradient Bis-Tris gel (Invitrogen) and 
electro-transferred onto Immobilon-P membranes (Millipore). The membranes were blocked with 3% powdered 
skim milk (BD Biosciences) in TBS [10 mM Tris-HCl (pH 8.0), 150 mM NaCl] with 0.05% Tween-20 at 4 °C for 
2 hrs, and then reacted with the primary antibody at RT for 2 hrs. The blots were subsequently incubated with 
horseradish peroxidase (HRP)-labeled goat anti-mouse IgG antibody (1:5000) for 2 hrs at RT. Finally, the proteins 
were visualized using enhanced chemiluminescence (ECL) reagents (Amersham Biosciences).
Animal Experiments. Fifteen PRRSV-free piglets (28 days old) were obtained from a PRRS free farm in 
Yangling and randomly divided into three groups. Group 1 piglets (n = 5) received PRRSV only, Group 2 piglets 
(n = 5) were given blebbistatin and challenged with PRRSV, and Group 3 piglets (n = 5) were used as the negative 
control. The animals were kept in 3 separate rooms and fed a commercial diet and water ad libitum throughout 
the experiment. Group 1 and 3 piglets were given PBS (2 ml) and Group 2 piglets were given 200 μ M of blebbista-
tin diluted in 2 ml of PBS intranasally (i.n.) per pig on experimental day (ED) 7 and 14. Group 1 and 2 piglets 
were challenged i.n. with PRRSV SD16 strain (7.5 × 105 TCID50/pig) on ED 8, and Group 3 piglets received PBS. 
Serum samples were collected on 7th day after the challenge from each piglet in Group 1 and 2, and virus titers 
were determined for TCID50. Piglets were monitored daily for 21 days, and the surviving piglets were euthanized 
21 days post infection. Lung and thymus tissues were collected for the histopathological examinations. Animal 
experiments were performed according to Chinese Regulations of Laboratory Animals and the approval license 
number was NWAFU (Shan) 20131017/02, which was approved by the Animal Care and Use Committee of 
Northwest A&F University.
Microscopic Pathological Examinations. Lung and thymus tissues were collected, fixed with 4% par-
aformaldehyde solution at room temperature for 48 h and then stained with hematoxylin and eosin (H&E) for 
observing pathological changes.
Statistical Methods. Student’s T test was performed with a value of P < 0.05 considered statistical signifi-
cant. ANOVA was used to identify significant group differences.
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